BDBM358081 ((2S,4R)-2-(3-(4-amino-5-(1-(tetrahydro-2H- pyran-4-yl)-1H-pyrazol-5-yl)pyrrolo[2,1-f][1,2,4] triazin-7-yl)phenyl)-4-hydroxypyrrolidin-1- yl)(pyridin-3-yl)methanone::US10214537, Example 150
SMILES: CC(C)[C@@H]1C[C@@H](O)CN1C(=O)c1cccnc1
InChI Key: InChIKey=UBUUNFPGICHHNJ-NEPJUHHUSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (Homo sapiens (Human)) | BDBM358081![]() (((2S,4R)-2-(3-(4-amino-5-(1-(tetrahydro-2H- pyran-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Co. US Patent | Assay Description The ADP-Glo format PI3K assays were performed in Proxiplate 384-well plates (Perkin Elmer #6008280). The final assay volume was 2 μl prepared fr... | US Patent US10214537 (2019) BindingDB Entry DOI: 10.7270/Q2HH6NB2 | |||||||||||
More data for this Ligand-Target Pair |